Biochemistry and physiology of mammalian secreted phospholipases A2.

Phospholipases A(2) (PLA2s) are esterases that hydrolyze the sn-2 ester of glycerophospholipids and constitute one of the largest families of lipid hydrolyzing enzymes. The mammalian genome contains 10 enzymatically active secreted PLA2s (sPLA2s) and two sPLA2-related proteins devoid of lipolytic enzymatic activity. In addition to the well-established functions of one of these enzymes in digestion of dietary phospholipids and another in host defense against bacterial infections, accumulating evidence shows that some of these sPLA2s are involved in arachidonic acid release from cellular phospholipids for the biosynthesis of eicosanoids, especially during inflammation. More speculative results suggest the involvement of one or more sPLA2s in promoting atherosclerosis and cancer. In addition, the mammalian genome encodes several types of sPLA2-binding proteins, and mounting evidence shows that sPLA2s may have functions related to binding to cellular target proteins in a manner independent of their lipolytic enzymatic activity.

[1]  M. Murakami,et al.  Expression of secretory phospholipase A2s in human atherosclerosis development. , 2008, Atherosclerosis.

[2]  B. Cummings Phospholipase A2 as targets for anti-cancer drugs. , 2007, Biochemical pharmacology.

[3]  Lidija Kovačič,et al.  A new photoprobe for studying biological activities of secreted phospholipases A2. , 2007, Bioorganic chemistry.

[4]  M. Murakami,et al.  A Novel Role of Group VIB Calcium-independent Phospholipase A2 (iPLA2γ) in the Inducible Expression of Group IIA Secretory PLA2 in Rat Fibroblastic Cells* , 2007, Journal of Biological Chemistry.

[5]  R. Ward,et al.  Mapping of the structural determinants of artificial and biological membrane damaging activities of a Lys49 phospholipase A2 by scanning alanine mutagenesis. , 2007, Biochimica et biophysica acta.

[6]  R. Luben,et al.  Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women: The EPIC-NORFOLK Study , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  James G. Bollinger,et al.  Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model , 2007, The Journal of experimental medicine.

[8]  R. Stábeli,et al.  Snake venom phospholipase A2 inhibitors: medicinal chemistry and therapeutic potential. , 2007, Current topics in medicinal chemistry.

[9]  C. Jordan,et al.  Group V Secretory Phospholipase A2 Promotes Atherosclerosis: Evidence From Genetically Altered Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Gelb,et al.  Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. , 2007, Biochemistry.

[11]  J. Musser,et al.  Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. , 2007, Trends in microbiology.

[12]  G. le Naour,et al.  Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Kei Yamamoto,et al.  Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction* , 2006, Journal of Biological Chemistry.

[14]  J. Mascola,et al.  Lysis of Human Immunodeficiency Virus Type 1 by a Specific Secreted Human Phospholipase A2 , 2006, Journal of Virology.

[15]  M. Gelb,et al.  Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor. , 2006, Biochemistry.

[16]  D. Rosenberg,et al.  Roles of cPLA2α and arachidonic acid in cancer , 2006 .

[17]  C. Leslie,et al.  Properties of the Group IV phospholipase A2 family. , 2006, Progress in lipid research.

[18]  J. D. Bell,et al.  A new hat for an old enzyme: waste management. , 2006, Biochimica et biophysica acta.

[19]  M. Triggiani,et al.  Activation of human inflammatory cells by secreted phospholipases A2. , 2006, Biochimica et biophysica acta.

[20]  E. Hurt-Camejo,et al.  Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis. , 2006, Biochimica et biophysica acta.

[21]  Edward A Dennis,et al.  The phospholipase A2 superfamily and its group numbering system. , 2006, Biochimica et biophysica acta.

[22]  O. Berg,et al.  Coupling of the i-face and the active site of phospholipase A2 for interfacial activation. , 2006, Current opinion in chemical biology.

[23]  J. Pfeilschifter,et al.  Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. , 2006, Kidney international.

[24]  F. Carrière,et al.  Exploring the specific features of interfacial enzymology based on lipase studies. , 2006, Biochimica et biophysica acta.

[25]  L. Horrocks,et al.  Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders , 2006, Pharmacological Reviews.

[26]  P. Sved,et al.  Oncogenic action of phospholipase A2 in prostate cancer. , 2006, Cancer letters.

[27]  M. Gelb,et al.  Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. , 2006, Biochimica et biophysica acta.

[28]  M. Gelb,et al.  Intracellular Actions of Group IIA Secreted Phospholipase A2 and Group IVA Cytosolic Phospholipase A2 Contribute to Arachidonic Acid Release and Prostaglandin Production in Rat Gastric Mucosal Cells and Transfected Human Embryonic Kidney Cells* , 2006, Journal of Biological Chemistry.

[29]  M. Gelb,et al.  Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity. , 2006, Biochemistry.

[30]  C. Garlanda,et al.  The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility , 2006, Journal of leukocyte biology.

[31]  S. Baek,et al.  Secretory phospholipase A2 induces apoptosis through TNF-α and cytochrome c-mediated caspase cascade in murine macrophage RAW 264.7 cells , 2006 .

[32]  M. Gelb,et al.  The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding. , 2006, Journal of medicinal chemistry.

[33]  K. Huggins,et al.  Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. , 2006, Diabetes.

[34]  G. Scott,et al.  sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism. , 2006, The Journal of investigative dermatology.

[35]  C. Leslie,et al.  Group V Secretory Phospholipase A2 Translocates to the Phagosome after Zymosan Stimulation of Mouse Peritoneal Macrophages and Regulates Phagocytosis* , 2006, Journal of Biological Chemistry.

[36]  G. Siegert,et al.  Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? , 2006, Prostaglandins & other lipid mediators.

[37]  D. Murray,et al.  Computational analysis of the membrane association of group IIA secreted phospholipases A2: a differential role for electrostatics. , 2006, Biochemistry.

[38]  M. Gelb,et al.  Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[39]  M. Murakami,et al.  Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells. , 2006, The Biochemical journal.

[40]  R. Reid,et al.  Inhibitors of secretory phospholipase A2 group IIA. , 2005, Current medicinal chemistry.

[41]  M. Mock,et al.  In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax1 , 2005, The Journal of Immunology.

[42]  W. Nauseef,et al.  Synergy between Extracellular Group IIA Phospholipase A2 and Phagocyte NADPH Oxidase in Digestion of Phospholipids of Staphylococcus aureus Ingested by Human Neutrophils1 , 2005, The Journal of Immunology.

[43]  W. Pruzanski,et al.  Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. , 2005, Biochimica et biophysica acta.

[44]  Suren A Tatulian,et al.  Positioning membrane proteins by novel protein engineering and biophysical approaches. , 2005, Journal of molecular biology.

[45]  Takashi Morita,et al.  Identification of Vascular Endothelial Growth Factor Receptor-binding Protein in the Venom of Eastern Cottonmouth , 2005, Journal of Biological Chemistry.

[46]  M. Murakami,et al.  Cellular Distribution, Post-translational Modification, and Tumorigenic Potential of Human Group III Secreted Phospholipase A2* , 2005, Journal of Biological Chemistry.

[47]  M. Murakami,et al.  Neuronal Expression and Neuritogenic Action of Group X Secreted Phospholipase A2* , 2005, Journal of Biological Chemistry.

[48]  N. Webb Secretory phospholipase A2 enzymes in atherogenesis , 2005, Current opinion in lipidology.

[49]  A. Brivanlou,et al.  Induction of Ectopic Olfactory Structures and Bone Morphogenetic Protein Inhibition by Rossy, a Group XII Secreted Phospholipase A2 , 2005, Molecular and Cellular Biology.

[50]  M. Gelb,et al.  Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. , 2005, Biochimica et biophysica acta.

[51]  M. Seeds,et al.  Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[52]  W. Pruzanski Phospholipase A2: quo vadis? , 2005, The Journal of rheumatology.

[53]  S. Myers,et al.  A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. , 2005, The Journal of rheumatology.

[54]  I. van der Made,et al.  Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400253-JLR200 , 2005, Journal of Lipid Research.

[55]  M. Gelb,et al.  Characterization and differentiation-dependent regulation of secreted phospholipases A in human keratinocytes and in healthy and psoriatic human skin. , 2005, The Journal of investigative dermatology.

[56]  James G. Bollinger,et al.  Interfacial binding of bee venom secreted phospholipase A2 to membranes occurs predominantly by a nonelectrostatic mechanism. , 2004, Biochemistry.

[57]  N. Bazan,et al.  Expression and location of mRNAs encoding multiple forms of secretory phospholipase A2 in the rat retina , 2004, Journal of neuroscience research.

[58]  M. Murakami Hot topics in phospholipase A2 field. , 2004, Biological & pharmaceutical bulletin.

[59]  Makoto Murakami,et al.  Secretory phospholipase A2. , 2004, Biological & pharmaceutical bulletin.

[60]  L. Touqui,et al.  High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin1 , 2004, The Journal of Immunology.

[61]  M. Gelb,et al.  Arachidonic Acid Release from Mammalian Cells Transfected with Human Groups IIA and X Secreted Phospholipase A2 Occurs Predominantly during the Secretory Process and with the Involvement of Cytosolic Phospholipase A2-α* , 2004, Journal of Biological Chemistry.

[62]  B. Lam,et al.  Role of Group V Phospholipase A2 in Zymosan-induced Eicosanoid Generation and Vascular Permeability Revealed by Targeted Gene Disruption* , 2004, Journal of Biological Chemistry.

[63]  James G. Bollinger,et al.  Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study. , 2004, Bioorganic & medicinal chemistry.

[64]  G. Rice,et al.  Phospholipase A2 isozymes in pregnancy and parturition. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[65]  T. Hla Prostaglandins & other lipid mediators: a new phase, a new team. , 2004, Prostaglandins & other lipid mediators.

[66]  M. Murakami,et al.  Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation. , 2003, Biochimica et biophysica acta.

[67]  J. Bonventre,et al.  Human Group V Phospholipase A2 Induces Group IVA Phospholipase A2-independent Cysteinyl Leukotriene Synthesis in Human Eosinophils* , 2003, Journal of Biological Chemistry.

[68]  M. Murakami,et al.  New phospholipase A2 isozymes with a potential role in atherosclerosis , 2003, Current opinion in lipidology.

[69]  James G. Bollinger,et al.  Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. , 2003, Biochemistry.

[70]  M. Gelb,et al.  Inhibitory Effects of Surfactant Protein A on Surfactant Phospholipid Hydrolysis by Secreted Phospholipases A21 , 2003, The Journal of Immunology.

[71]  J. Bonventre,et al.  Cross-talk between Cytosolic Phospholipase A2α (cPLA2α) and Secretory Phospholipase A2 (sPLA2) in Hydrogen Peroxide-induced Arachidonic Acid Release in Murine Mesangial Cells , 2003, Journal of Biological Chemistry.

[72]  G. Graham,et al.  Secreted phospholipase A2 enzymes as therapeutic targets , 2003, Expert opinion on therapeutic targets.

[73]  S. Bourgoin,et al.  Interaction of low molecular weight group IIA phospholipase A2 with apoptotic human T cells: role of heparan sulfate proteoglycans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  M. Gelb,et al.  Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2. , 2003, Biochemistry.

[75]  K. Naresh,et al.  Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis , 2003, Oncogene.

[76]  M. Gelb,et al.  Cellular Arachidonate-releasing Function of Novel Classes of Secretory Phospholipase A2s (Groups III and XII)* , 2003, The Journal of Biological Chemistry.

[77]  Jennifer L. Martin,et al.  D‐Tyrosine as a Chiral Precusor to Potent Inhibitors of Human Nonpancreatic Secretory Phospholipase A2 (IIa) with Antiinflammatory Activity , 2003, Chembiochem : a European journal of chemical biology.

[78]  A. Daugherty,et al.  Macrophage-Expressed Group IIA Secretory Phospholipase A2 Increases Atherosclerotic Lesion Formation in LDL Receptor-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[79]  M. Gelb,et al.  Interfacial Kinetic and Binding Properties of the Complete Set of Human and Mouse Groups I, II, V, X, and XII Secreted Phospholipases A2 * , 2002, The Journal of Biological Chemistry.

[80]  James G. Bollinger,et al.  On the Binding Preference of Human Groups IIA and X Phospholipases A2 for Membranes with Anionic Phospholipids* , 2002, The Journal of Biological Chemistry.

[81]  M. Gelb,et al.  Role of Charge Properties of Bacterial Envelope in Bactericidal Action of Human Group IIA Phospholipase A2against Staphylococcus aureus* , 2002, The Journal of Biological Chemistry.

[82]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  K. Huggins,et al.  Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[84]  H. Sano,et al.  Group V Phospholipase A2 Induces Leukotriene Biosynthesis in Human Neutrophils through the Activation of Group IVA Phospholipase A2 * , 2002, The Journal of Biological Chemistry.

[85]  M. Gelb,et al.  Unusual Mode of Binding of Human Group IIA Secreted Phospholipase A2 to Anionic Interfaces as Studied by Continuous Wave and Time Domain Electron Paramagnetic Resonance Spectroscopy* , 2002, The Journal of Biological Chemistry.

[86]  Katsutoshi Yamada,et al.  Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation* , 2002, The Journal of Biological Chemistry.

[87]  M. Gelb,et al.  Crystal Structure of Human Group X Secreted Phospholipase A2 , 2002, The Journal of Biological Chemistry.

[88]  H. Arita,et al.  Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. , 2002, Prostaglandins & other lipid mediators.

[89]  M. Schotz,et al.  The lipase gene family DOI 10.1194/jlr.R200007-JLR200 , 2002, Journal of Lipid Research.

[90]  W. Cho,et al.  Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. , 2002, Biochemistry.

[91]  M. Gelb,et al.  Bactericidal Properties of Human and Murine Groups I, II, V, X, and XII Secreted Phospholipases A2 * , 2002, The Journal of Biological Chemistry.

[92]  O. Berg,et al.  Interfacial Enzyme Kinetics , 2002 .

[93]  M. Gelb,et al.  The Antibacterial Properties of Secreted Phospholipases A2 , 2002, The Journal of Biological Chemistry.

[94]  L. Touqui,et al.  Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. , 2001, Current molecular medicine.

[95]  P. Kovanen,et al.  Phospholipase A(2) in vascular disease. , 2001, Circulation research.

[96]  G. Lambeau,et al.  A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. , 2001, Molecular pharmacology.

[97]  K. Kitatani,et al.  Secretory Phospholipase A2 Mediates Cooperative Prostaglandin Generation by Growth Factor and Cytokine Independently of Preceding Cytosolic Phospholipase A2 Expression in Rat Gastric Epithelial Cells* , 2001, The Journal of Biological Chemistry.

[98]  W. Pruzanski,et al.  Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2 , 2001, Laboratory Investigation.

[99]  R. Kini,et al.  Anticoagulant Venom and Mammalian Secreted Phospholipases A2: Protein- versus Phospholipid-Dependent Mechanism of Action , 2001, Pathophysiology of Haemostasis and Thrombosis.

[100]  A. Matsukawa,et al.  Therapeutic time-window of a group IIA phospholipase A2 inhibitor in rabbit acute lung injury: Correlation with lung surfactant protection , 2001, Critical care medicine.

[101]  P. Tso,et al.  Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A(2)-deficient mice. , 2001, Gastroenterology.

[102]  T. Nevalainen,et al.  Group II PLA(2) content of tears in normal subjects. , 2001, Investigative ophthalmology & visual science.

[103]  H. Arita,et al.  Potential role of group X secretory phospholipase A2 in cyclooxygenase‐2‐dependent PGE2 formation during colon tumorigenesis , 2000, FEBS letters.

[104]  C. Deregnaucourt,et al.  Bee Venom Phospholipase A2 Induces Stage-specific Growth Arrest of the Intraerythrocytic Plasmodium falciparum via Modifications of Human Serum Components* , 2000, The Journal of Biological Chemistry.

[105]  M. Gelb,et al.  Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). , 2000, Biochemical and biophysical research communications.

[106]  G. Lambeau,et al.  Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. , 2000, Biochimica et biophysica acta.

[107]  D. Wilton,et al.  The antibacterial properties of secreted phospholipases A(2). , 2000, Biochimica et biophysica acta.

[108]  M. Matzuk,et al.  Biochemical Interactions of the Neuronal Pentraxins , 2000, The Journal of Biological Chemistry.

[109]  M. Gelb,et al.  Novel Human Secreted Phospholipase A2 with Homology to the Group III Bee Venom Enzyme* , 2000, The Journal of Biological Chemistry.

[110]  T. Nevalainen,et al.  Resistance of Transgenic Mice Expressing Human Group II Phospholipase A2 to Escherichia coliInfection , 2000, Infection and Immunity.

[111]  K. Kawamoto,et al.  Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells* , 1999, The Journal of Biological Chemistry.

[112]  R. Schevitz,et al.  Structure-based design of a new class of anti-inflammatory drugs: Secretory phospholipase A2 inhibitors, SPI , 1999 .

[113]  M. Gelb,et al.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. , 1999, The Journal of biological chemistry.

[114]  K. Kugiyama,et al.  Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease. , 1999, Circulation.

[115]  M. Gelb,et al.  Interfacial binding of secreted phospholipases A(2): more than electrostatics and a major role for tryptophan. , 1999, Current opinion in structural biology.

[116]  L. Touqui,et al.  A role for phospholipase A2 in ARDS pathogenesis. , 1999, Molecular medicine today.

[117]  J. Qiao,et al.  Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[118]  J. Balsinde,et al.  Regulation of Delayed Prostaglandin Production in Activated P388D1 Macrophages by Group IV Cytosolic and Group V Secretory Phospholipase A2s* , 1999, The Journal of Biological Chemistry.

[119]  M. Gelb,et al.  Roles of Trp31 in High Membrane Binding and Proinflammatory Activity of Human Group V Phospholipase A2 * , 1999, The Journal of Biological Chemistry.

[120]  M. Lazdunski,et al.  Receptors for a growing family of secreted phospholipases A2. , 1999, Trends in pharmacological sciences.

[121]  C. Petit,et al.  Characterization of otoconin-95, the major protein of murine otoconia, provides insights into the formation of these inner ear biominerals. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Weiss,et al.  Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. , 1998, The Journal of clinical investigation.

[123]  M. Murakami,et al.  The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid Release , 1998, The Journal of Biological Chemistry.

[124]  B. Lomonte,et al.  Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. , 1998, European journal of biochemistry.

[125]  M. Gelb,et al.  Docking phospholipase A2 on membranes using electrostatic potential-modulated spin relaxation magnetic resonance. , 1998, Science.

[126]  H. Tojo,et al.  Identification of Functional Domains of Rat Intestinal Phospholipase B/Lipase , 1998, The Journal of Biological Chemistry.

[127]  J. Miyazaki,et al.  Role of cytosolic phospholipase A2 in allergic response and parturition , 1997, Nature.

[128]  M. Gelb,et al.  Mapping the interfacial binding surface of human secretory group IIa phospholipase A2. , 1997, Biochemistry.

[129]  M. Lazdunski,et al.  Cloning, Chromosomal Mapping, and Expression of a Novel Human Secretory Phospholipase A2 * , 1997, The Journal of Biological Chemistry.

[130]  P. Sigler,et al.  Structural Aspects of Interfacial Adsorption , 1997, The Journal of Biological Chemistry.

[131]  D. R. Berry,et al.  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides. , 1996, Journal of medicinal chemistry.

[132]  D. R. Berry,et al.  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality. , 1996, Journal of medicinal chemistry.

[133]  Stephen H. White,et al.  Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.

[134]  J. L. Bobbitt,et al.  Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. , 1996, The Journal of pharmacology and experimental therapeutics.

[135]  C. F. Bennett,et al.  Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. , 1996, The Journal of clinical investigation.

[136]  P. Elias,et al.  Secretory phospholipase A2 activity is required for permeability barrier homeostasis. , 1996, The Journal of investigative dermatology.

[137]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[138]  D. Wilton,et al.  Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate. , 1995, The Biochemical journal.

[139]  J.-P. Wery,et al.  Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2 , 1995, Nature Structural Biology.

[140]  L. Sarda,et al.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells , 1995, Cell.

[141]  R. Lehrer,et al.  Bactericidal properties of murine intestinal phospholipase A2. , 1995, The Journal of clinical investigation.

[142]  O. Berg,et al.  Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. , 1995, Annual review of biochemistry.

[143]  O. Berg,et al.  Inhibition of phospholipase A2 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  N. Gensmantel,et al.  Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2. , 1994, Journal of medicinal chemistry.

[145]  P. Sigler,et al.  Structure and catalytic mechanism of secretory phospholipases A2. , 1994, Advances in protein chemistry.

[146]  J. Browning,et al.  Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. , 1993, Journal of lipid mediators.

[147]  M. Gelb,et al.  Competitive inhibition of interfacial catalysis by phospholipase A2: differential interaction of inhibitors with the vesicle interface as a controlling factor of inhibitor potency , 1993 .

[148]  O. Berg,et al.  Assay of phospholipases A2 and their inhibitors by kinetic analysis in the scooting mode , 1992, Mediators of inflammation.

[149]  J. J. Rosa,et al.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. , 1993, Science.

[150]  M. Gelb,et al.  Kinetic characterization of phospholipase A2 modified by manoalogue. , 1991, Biochemistry.

[151]  O. Berg,et al.  Quantitative and structural analysis of inhibitors of phospholipase A2 , 1991 .

[152]  R. Jacobs,et al.  Two-step inactivation of bee venom phospholipase A2 by scalaradial. , 1991, Biochemical pharmacology.

[153]  O. Berg,et al.  Interfacial catalysis by phospholipase A2: substrate specificity in vesicles. , 1991, Biochemistry.

[154]  O. Berg,et al.  Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors. , 1991, Biochemistry.

[155]  Mahendra K. Jain,et al.  Phospholipase A2 at the bilayer interface , 1991, Proteins.

[156]  O. Kuipers,et al.  Probing the mechanism of pancreatic phospholipase A2 with the aid of recombinant DNA techniques. , 1990, Advances in experimental medicine and biology.

[157]  K. Glaser,et al.  Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. , 1989, Molecular pharmacology.

[158]  R. Kini,et al.  A model to explain the pharmacological effects of snake venom phospholipases A2. , 1989, Toxicon : official journal of the International Society on Toxinology.

[159]  M. Jain,et al.  Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles. , 1986, Biochimica et biophysica acta.

[160]  E. Dennis,et al.  Analysis of the kinetics of phospholipid activation of cobra venom phospholipase A2. , 1984, The Journal of biological chemistry.

[161]  H. Verheij,et al.  Structure and function of phospholiphase A2 , 1981 .

[162]  A. Schneider,et al.  Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. , 1979, The Journal of biological chemistry.